Edition:
India

Cytori Therapeutics Inc (CYTX.OQ)

CYTX.OQ on NASDAQ Stock Exchange Capital Market

1.89USD
22 Jun 2018
Change (% chg)

$-0.15 (-7.35%)
Prev Close
$2.04
Open
$2.19
Day's High
$2.19
Day's Low
$1.74
Volume
113,868
Avg. Vol
16,530
52-wk High
$12.10
52-wk Low
$1.65

Latest Key Developments (Source: Significant Developments)

Cytori Therapeutics Enters Agreement With B. Riley FBR To Sell Its Shares
Saturday, 2 Jun 2018 

June 1 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS INC - ON JUNE 1, ENTERED SALES AGREEMENT WITH B. RILEY FBR TO SELL ITS SHARES WITH AGGREGATE OFFERING PRICE OF UP TO $6.5 MILLION.  Full Article

Swissquote Bank SA Reports 12 pct Passive Stake In Cytori Therapeutics As Of Dec. 29, 2017
Tuesday, 9 Jan 2018 

Jan 8 (Reuters) - Cytori Therapeutics Inc ::SWISSQUOTE BANK SA REPORTS 12 PERCENT PASSIVE STAKE IN CYTORI THERAPEUTICS INC AS OF DECEMBER 29, 2017 - SEC FILING‍​.  Full Article

Cytori Therapeutics Inc ‍announces new investigator initiated U.S. clinical trial for hip osteonecrosis​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Cytori Therapeutics Inc :Cytori Therapeutics Inc - ‍announced a new investigator initiated U.S. clinical trial for hip osteonecrosis​.  Full Article

Cytori reports Q3 loss per share $0.14
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Cytori Therapeutics Inc :Cytori reports third quarter 2017 business and financial results.Q3 loss per share $0.14.Cytori Therapeutics Inc - ‍received U.S. FDA IDE approval for relief, a thermal burn pilot trial related to ongoing barda contract​.Cytori Therapeutics Inc - ‍expects full year 2017 operating cash burn to be lower than 2016, primarily due to restructuring announced in September 2017​.  Full Article

Cytori Therapeutics Q2 loss per share $0.43
Friday, 5 Aug 2016 

Cytori Therapeutics Inc : Cytori reports second quarter 2016 business and financial results . Q2 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S . Q2 loss per share $0.43 . Reiterated financial guidance for 2016 .Says q2 total revenues of $2.8 million versus $5.8 million for same periods in 2015.  Full Article

BRIEF-Cytori Therapeutics Common Stock To Begin Trading On Adjusted Basis On May 24

* CYTORI THERAPEUTIC’S COMMON STOCK TO BEGIN TRADING ON ADJUSTED BASIS ON MAY 24, FOLLOWING ONE-FOR-TEN REVERSE SPLIT Source text for Eikon: Further company coverage: